Displaying items by tag: division of hematology and oncology

Mortgage lending discrimination in the 1930s is still geographically associated with inequities in colon cancer care today. Colon cancer often can be treated successfully if detected early.
Sickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD.
One UAB experts says the roles of screenings, warning signs and a healthy lifestyle are all keys to cancer prevention.
After a loved one receives a breast cancer diagnosis or surgery, it is important for caregivers and support partners to know how they can best help the patient during the difficult time.
The O’Neal Comprehensive Cancer Center at UAB is recruiting Alabama women who have never had breast cancer for the study, to test a personalized approach to breast cancer screening.
An overabundance of mast cells, which are important components of the immune system and are produced in the bone marrow, can lead to a variety of health issues.
When Cameron Monistere was diagnosed with cancer right before his senior year of college and final season as an Auburn University cheerleader, he acted fast. With the help of UAB experts, Monistere is now cancer-free and using his story to raise awareness about men’s health.
Direct reprogramming is a potential therapy for heart attack patients. In vitro, TBX20 improved contractility and mitochondrial function of reprogrammed heart muscle cells.
UAB’s CAR T-cell therapy cured stage 4 lymphoma with the help of the patient’s resilience and the doctor’s timely diagnosis and treatment.
Results published in the Journal of Alzheimer’s Disease show patients with one cancer diagnosis were less likely to develop dementia and had an overall slower cognitive decline than patients with no history of cancer.  

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.

The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.

Page 1 of 6